p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Ravaioli, A.A.RavaioliMonti, F.F.MontiRegan, M. M.M. M.ReganMaffini, F.F.MaffiniMastropasqua, M. G.M. G.MastropasquaSpataro, V.V.SpataroCastiglione, MonicaMonicaCastiglionePanzini, I.I.PanziniGianni, L.L.GianniGoldhirsch, A.A.GoldhirschCoates, A.A.CoatesPrice, K. N.K. N.PriceGusterson, B. A.B. A.GustersonViale, G.G.Viale2024-10-252024-10-252008https://boris-portal.unibe.ch/handle/20.500.12422/161273en600 - Technology::610 - Medicine & healthp27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerarticle10.7892/boris.11557610.1093/annonc/mdm547